Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aqueous extract of broccoli seed is a dietary supplement and nutraceutical ingredient derived from the seeds of the Brassica oleracea (broccoli) plant, using water-based extraction methods. The primary bioactive components are glucoraphanin (a glucosinolate), myrosinase (an enzyme), and sulforaphane, which is produced when glucoraphanin is converted by myrosinase during digestion[2][1]. Sulforaphane acts as a potent inducer of phase II detoxification enzymes, supports antioxidant defenses via Nrf2 pathway activation, reduces inflammation, and may have anticancer properties[7][8]. The product is used in supplements for cellular health support, detoxification enhancement, anti-inflammatory effects, cardiovascular health improvement, metabolic support in diabetes management, and as an ingredient in cosmetics for its antioxidant properties[4][6][9]. It is not an approved pharmaceutical drug but widely marketed as a dietary supplement or cosmetic ingredient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aqueous extract of broccoli seed.